Avicenna.AI has received clearance from the U.S. Food and Drug Administration for its CINA-CSpine tool, an artificial intelligence application designed to help doctors quickly detect cervical spine fractures in CT scans. These injuries, often caused by trauma, can lead to serious complications such as nerve damage or paralysis if not diagnosed and treated promptly.
The CINA-CSpine tool uses deep learning technology to automatically flag potential fractures and alert radiologists within seconds, integrating with the systems they already use. The goal is to speed up the process of diagnosis, ensuring that critical cases are prioritized for treatment.
Cyril Di Grandi, Avicenna.AI’s co-founder and CEO, highlighted the importance of quick diagnosis in these cases. “Cervical spine fractures are serious and require immediate attention, especially when the spinal cord is involved,” he said. “This tool aims to cut down the time between the scan and diagnosis, which can make a big difference in a patient’s recovery.”
The tool was tested on more than 300 CT scans from various sources across the U.S. and Europe, achieving a sensitivity of 90.3% and specificity of 91.9%. These results were compared to assessments made by a group of experienced radiologists.
In addition to its potential clinical impact, the tool could also help reduce legal risks. Missed diagnoses of cervical spine fractures are relatively rare but can result in costly lawsuits, with legal costs in the U.S. sometimes reaching millions of dollars.
The CINA-CSpine tool is the latest in Avicenna.AI’s suite of AI applications, which includes tools for detecting conditions like intracranial hemorrhage, pulmonary embolism, and aortic dissection. The company’s technology is designed to integrate seamlessly into radiologists’ existing workflows, helping them quickly identify and prioritize urgent cases.